MyMD Phase 2 Study Hits Key Goals in Age-Related Frailty MYMD By Colin Kellaher MyMD Pharmaceuticals on Monday reported positive topline results from a Phase 2 study of its lead product candidate in patients with...

MyMD Phase 2 Study Hits Key Goals in Age-Related Frailty MYMD

About 67% of MYMD Old's investor base is looking to short. The analysis of current outlook of investing in MYMD Old suggests that many traders are alarmed regarding MYMD Old's prospects. The current market sentiment, together with MYMD Old's historical and current headlines, can help investors time the market. In addition, many technical investors use MYMD Old stock news signals to limit their universe of possible portfolio assets.
  
By Colin Kellaher MyMD Pharmaceuticals on Monday reported positive topline results from a Phase 2 study of its lead product candidate in patients with...

Read at marketwatch.com
marketwatch News
  

MYMD Old Fundamental Analysis

We analyze MYMD Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MYMD Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MYMD Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Debt To Equity

Debt To Equity Comparative Analysis

MYMD Old is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

MYMD Old Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MYMD Old stock to make a market-neutral strategy. Peer analysis of MYMD Old could also be used in its relative valuation, which is a method of valuing MYMD Old by comparing valuation metrics with similar companies.

Peers

MYMD Old Related Equities

PASGPassage Bio   0.33   
0%
2.0%
KRONKronos Bio   0.15   
0%
1.0%
REVBRevelation Biosciences   0.00   
0%
0%
XBIOXenetic Biosciences   0.00   
0%
0%
GOVXGeoVax Labs   0.46   
3.0%
0%
KROSKeros Therapeutics   1.49   
10.0%
0%
DSGNDesign Therapeutics   1.91   
13.0%
0%
LGNDLigand Pharmaceuticals   2.35   
17.0%
0%
LYELLyell Immunopharma   2.38   
17.0%
0%
ORICOric Pharmaceuticals   2.39   
17.0%
0%
KZRKezar Life   2.43   
17.0%
0%
GOSSGossamer Bio   2.54   
18.0%
0%
AVIRAtea Pharmaceuticals   3.10   
22.0%
0%
UBXUnity Biotechnology   3.90   
28.0%
0%
BOLTBolt Biotherapeutics   3.94   
28.0%
0%
NBYNovaBay Pharmaceuticals   5.08   
37.0%
0%
NVCTNuvectis Pharma   5.63   
41.0%
0%
LRMRLarimar Therapeutics   6.31   
46.0%
0%
REPLReplimune   7.94   
57.0%
0%
RXRXRecursion Pharmaceuticals   9.89   
72.0%
0%
SRZNSurrozen   13.70   
100.0%
0%
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Consideration for investing in MYMD Stock

If you are still planning to invest in MYMD Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MYMD Old's history and understand the potential risks before investing.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio